Charcot-Marie-Tooth disease type 1F
MONDO:0011902A form of CMT1, with a variable clinical presentation that can range from severe impairment with onset in childhood to mild impairment appearing during adulthood. CMT1F is characterized by a progressive peripheral motor and sensory neuropathy with distal paresis in the lower limbs that varies from mild weakness to complete paralysis of the distal muscle groups, absent tendon reflexes and reduced nerve conduction. CMT1F represents the ''demyelinating'' form of CMT2E and is caused by mutations in the NEFL gene (8p21.2)..
Also known as: CMT1F, Charcot-Marie-Tooth disease type 1 caused by mutation in NEFL, Charcot-Marie-Tooth disease, type 1F, NEFL Charcot-Marie-Tooth disease type 1, CMT 1F, Charcot Marie Tooth disease type 1F, Charcot-Marie-Tooth disease, demyelinating, type 1F, Charcot-Marie-Tooth neuropathy, type 1F
27 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Gene therapy readiness check: new study maps virus immunity in muscle disease patients
Knowledge-focused Not yet recruitingThis study will test blood samples from 450 people aged 6 to 60 with inherited neuromuscular diseases to see if they have antibodies that could block gene therapy viruses (AAVs). The goal is to understand how common these antibodies are and which patients might be good candidates…
Phase: NA • Sponsor: Genethon • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Can blood tests spot Alzheimer's risk in all ethnicities? barcelona study aims to find out
Knowledge-focused Not yet recruitingThis study will check if levels of Alzheimer's-related substances in the blood differ among the main ethnic groups living in central Barcelona. Researchers will also look at how age, income, education, and health conditions affect these levels. The goal is to identify barriers to…
Sponsor: Barcelonabeta Brain Research Center, Pasqual Maragall Foundation • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Exercise may shield MS brains from damage, small trial hopes to show
Knowledge-focused Not yet recruitingThis study will test whether a 12-week progressive resistance training program can improve brain health in people with relapsing-remitting multiple sclerosis. Researchers will measure brain volume and a nerve damage marker in the blood. The trial involves 26 participants and aims…
Phase: NA • Sponsor: Firat University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
New blood test may predict brain damage in Oxygen-Deprived newborns
Knowledge-focused Not yet recruitingThis study looks at whether a protein called neurofilament light chain (NfL) in the blood can help measure brain injury in newborns with hypoxic-ischemic encephalopathy (HIE), a condition caused by lack of oxygen at birth. Researchers will measure NfL levels at several time point…
Sponsor: Mustafa Gürkan • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC